Results 11 to 20 of about 236,526 (353)

Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China.

Gastroenterology, 2023
BACKGROUND & AIMS This study aimed to estimate the prevalence of liver steatosis and fibrosis in the general population and populations with potential risk factors in China, so as to inform policies for the screening and management of fatty liver disease
S. Man, Yuhan Deng, Yuan Ma, Jingzhu Fu, Heling Bao, Canqing Yu, J. Lv, Hui Liu, Bo Wang, Liming Li   +9 more
semanticscholar   +1 more source

The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis

Nature Communications, 2023
Dietary lipids can affect metabolic health through gut microbiota-mediated mechanisms, but the influence of lipid-microbiota interaction on liver steatosis is largely unknown.
M. Schoeler, S. Ellero-Simatos, Till Birkner, J. Mayneris‐Perxachs, Lisa M. Olsson, Harald Brolin, U. Loeber, Jamie D Kraft, Arnaud Polizzi, Marian Martí-Navas, Josep Puig, A. Moschetta, A. Montagner, P. Gourdy, Christophe Heymes, Hervé Guillou, V. Tremaroli, J. Fernández-Real, S. Forslund, Rémy Burcelin, R. Caesar   +20 more
semanticscholar   +1 more source

Association between SII and hepatic steatosis and liver fibrosis: A population-based study

Frontiers in Immunology, 2022
Background The systemic immune-inflammation index (SII) is a novel marker of inflammation, and hepatic steatosis and fibrosis are associated with inflammation.
R. Xie, M. Xiao, Lihong Li, Nengqian Ma, Mingjiang Liu, Xiongjie Huang, Qianlong Liu, Ya Zhang   +7 more
semanticscholar   +1 more source

Systemic immune-inflammation index is associated with hepatic steatosis: Evidence from NHANES 2015-2018

Frontiers in Immunology, 2022
Background As a novel inflammatory marker, Systemic Immune-Inflammation Index (SII) has not been studied with hepatic steatosis. The aim of this study was to investigate the possible relationship between SII and hepatic steatosis.
Yancheng Song, Wencong Guo, Zhaopeng Li, D. Guo, Zhaopeng Li, Y. Li   +5 more
semanticscholar   +1 more source

Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity [PDF]

, 2016
Objective: This study aimed to evaluate whether circulating levels and/or visceral adipose tissue (VAT) expression of recently described adipokines associate with histopathological severity of nonalcoholic fatty liver disease (NAFLD), independent of ...
Alfadda, Behari, Bekaert, Bozaoglu, Brunt, Bugianesi, Chakaroun, Deng, Docke, Donnelly, Ehrlund, Fuster, Greulich, Gruben, Haukeland, Heiker, Kanda, Kim, Kleiner, Luangsay, Mahdi, Marchesini, Musso, Ouwens, Polyzos, Polyzos, Rivera, Saxena, Seki, Sell, Sell, Souza Batista, Wittamer, Wittamer, Wolfs, Wong, Yang, Yilmaz, Zelber-Sagi, Zeng   +39 more
core   +1 more source

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

BMC Gastroenterology, 2006
BackgroundFatty liver (FL) is the most frequent liver disease in Western countries. We used data from the Dionysos Nutrition & Liver Study to develop a simple algorithm for the prediction of FL in the general population.Methods216 subjects with and 280 ...
G. Bedogni, S. Bellentani, L. Miglioli, F. Masutti, M. Passalacqua, A. Castiglione, C. Tiribelli   +6 more
semanticscholar   +1 more source

Nickel Nanoparticles Induced Hepatotoxicity in Mice via Lipid-Metabolism-Dysfunction-Regulated Inflammatory Injury

Molecules, 2023
Nickel nanoparticles (NiNPs) have wide applications in industry and biomedicine due to their unique characteristics. The liver is the major organ responsible for nutrient metabolism, exogenous substance detoxification and biotransformation of medicines ...
Shuang Zhou, Hua Li, Hui Wang, Rui Wang, Wei Song, Da Li, Changlei Wei, Yu Guo, Xueying He, Yulin Deng   +9 more
doaj   +1 more source

Chemerin and Chemokine-like Receptor 1 Expression Are Associated with Hepatocellular Carcinoma Progression in European Patients

Biomedicines, 2023
The chemoattractant protein chemerin is protective in experimental hepatocellular carcinoma (HCC), and high expression in HCC tissues of Asian patients was related to a favorable prognosis.
Florian Weber, Kirsten Utpatel, Katja Evert, Oliver Treeck, Christa Buechler   +4 more
doaj   +1 more source

Ultrasound-based techniques for the diagnosis of liver steatosis

World Journal of Gastroenterology, 2019
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of diffuse liver disease. An accurate estimate of the fat in the liver is important in the diagnostic work-up of patients with NAFLD because the degree of liver steatosis is linked to the ...
G. Ferraioli, Livia Beatriz Soares Monteiro   +1 more
semanticscholar   +1 more source

Alterations in DNA methylation associate with fatty liver and metabolic abnormalities in a multi-ethnic cohort of pre-teenage children

Epigenetics, 2022
Non-Alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children. Epigenetic alterations, such as through DNA methylation (DNAm), may link adverse childhood exposures and fatty liver and provide non-invasive methods for
Cynthia A. Moylan, Alisha M. Mavis, Dereje Jima, Rachel Maguire, Mustafa Bashir, Jeongeun Hyun, Melanie N. Cabezas, Alice Parish, Donna Niedzwiecki, Anna Mae Diehl, Susan K. Murphy, Manal F. Abdelmalek, Cathrine Hoyo   +12 more
doaj   +1 more source